T44.7X2 Poisoning by beta-adrenoreceptor antagonists, intentional self-harm

Name of the Condition

• Poisoning by beta-adrenoreceptor antagonists, intentional self-harm
• This code represents intentional self-harm resulting from exposure to beta-adrenoreceptor antagonists (beta-blockers).

Summary

Intentional self-harm by beta-adrenoreceptor antagonists involves deliberate ingestion or exposure to excessive amounts of beta-blockers, leading to toxic effects. Beta-blockers are medications used to manage cardiovascular conditions like hypertension, angina, and arrhythmias. This code specifically applies when the poisoning is self-inflicted.

Causes

Intentional self-harm may result from deliberate overdose, misuse of prescribed medications, or intentional exposure to beta-blockers. It can occur due to intentional ingestion of higher-than-prescribed doses or use of multiple beta-blocker formulations.

Risk Factors

• Concurrent use of multiple medications affecting cardiovascular function.
• Pre-existing conditions that alter drug metabolism or sensitivity (e.g., asthma, diabetes).
• Age-related changes in drug response (e.g., elderly or pediatric patients).
• History of substance use or misuse.
• Mental health conditions or suicidal ideation.

Symptoms

• Bradycardia (slow heart rate) or hypotension (low blood pressure).
• Dizziness, fatigue, or syncope (fainting).
• Cold extremities or cyanosis.
• Respiratory distress or bronchospasm.
• Seizures or altered mental status.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, medication history, and toxicology screening. Healthcare providers assess the timing and circumstances of exposure, along with physical examination findings. Laboratory tests may confirm beta-blocker levels, and electrocardiography (ECG) can identify cardiac abnormalities.

Treatment Options

Treatment focuses on stabilizing the patient, supporting vital functions, and preventing further absorption. Interventions may include activated charcoal, intravenous fluids, and medications to manage bradycardia or hypotension. In severe cases, intensive care monitoring or mechanical ventilation may be required.

Prognosis and Follow-Up

Prognosis depends on the dose ingested, time to treatment, and underlying health status. Early intervention improves outcomes. Follow-up care includes monitoring for complications, addressing mental health needs, and ensuring medication safety. Long-term management may involve psychiatric evaluation and support.

Complications

• Severe bradycardia or cardiac arrest.
• Prolonged hypotension leading to organ damage.
• Respiratory failure or aspiration.
• Neurological deficits from hypoxia.
• Recurrent self-harm or overdose.

Lifestyle & Prevention

• Secure storage of medications to prevent access.
• Education on proper medication use and disposal.
• Mental health support for at-risk individuals.
• Regular follow-up with healthcare providers to address adherence and safety.

When to Seek Professional Help

Seek immediate medical attention if intentional self-harm is suspected or if symptoms like severe dizziness, fainting, or difficulty breathing occur. Prompt care is critical to prevent life-threatening complications.

Tips for Medical Coders

• Use this code for cases of intentional self-harm involving beta-adrenoreceptor antagonists.
• Document the intent (intentional self-harm) clearly in the medical record.
• Ensure the code aligns with the clinical scenario and documentation of the encounter.
• Verify no other codes (e.g., for underlying conditions) conflict with this code’s application.